North American Immuno-Hematology Clinical Education & Research (NICER) Symposium - X4 Pharmaceuticals

North American Immuno-Hematology Clinical Education & Research (NICER) Symposium

North American Immuno-Hematology Clinical Education & Research (NICER) Symposium

September 2022

Administration of Mavorixafor, an Orally Available CXCR4 Antagonist, Increases Total White Blood Cell, Neutrophil, Lymphocyte, and Monocyte Counts Across Different Disease States
Characterization of Novel CXCR4 Variants to Support Expanded Genetic Testing for WHIM Syndrome Phenotypes

© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy | Compliance and Ethics